SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

Q460N5 (PAR14_HUMAN) Homo sapiens (Human)

Protein mono-ADP-ribosyltransferase PARP14 UniProtKBInterProSTRINGInteractive Modelling

1801 aa; Sequence (Fasta) ; (Isoform 1; Isoform 3; Isoform 4; Isoform 5)

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5homo-2-mer1611-1801
100.07AG;
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor MCD72homo-2-mer1613-1801
100.0EGW;
Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhi…homo-2-mer1613-1801
100.0XL2;
Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphatemonomer791-1191
100.0ADP;
Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphoribosemonomer791-1191
100.0AR6;
Human parp14 (artd8) - macro domain 2 in complex with adenosine-5-diphosphoribosemonomer999-1191
100AR6;
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H10monomer1612-1801
100.07B8;
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK6monomer1612-1801
100EE5;
Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitormonomer1612-1801
100.094Z;
PARP14 Macrodomain 2 with inhibitormonomer1002-1190
97.889HH;
Human PARP14 (ARTD8), catalytic fragment in complex with compound 3monomer1613-1801
100.0TZ7;EDO;PEG;GOL;SO4;
PARP14 catalytic domain in complex with OUL40monomer1613-1801
100.0I1Q;CL;
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK1monomer1613-1801
100EBB;
Human poly(ADP-ribose) polymerase 14 (PARP14/ARTD8) - catalytic domain in complex with 6(5H)-phenan…monomer1613-1801
100.0LDR;GOL;
crystal structure of PARP14 bound to N-{4-[4-(diphenylmethoxy)piperidin-1-yl]butyl}[1,2,4]triazolo[…monomer1613-1801
100.091V;
Human PARP14 (ARTD8), catalytic fragment in complex with RBN012759monomer1613-1801
100XBA;EDO;
Crystal structure of human poly(adp-ribose) polymerase 14, catalytic fragment in complex with an in…monomer1613-1801
100.03AB;
Human Artd8 (Parp14, Bal2) - catalytic domain in complex with A16(E)monomer1613-1801
100.00RZ;
Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a pyrimidine…monomer1614-1801
100FDR;GOL;
Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrah…monomer1614-1801
100.091J;
Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z)monomer1615-1801
1000RY;NO3;
HUman PARP14 (ARTD8)-Macro domain 1 in complex with adenosine-5-diphosphoribosemonomer792-978
100.0APR;
Human PARP14 (ARTD8), catalytic fragment in complex with RBN012042monomer1615-1801
100XRM;CL;EDO;
Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a quinazolin…monomer1615-1801
100.0QDR;
Human PARP14 (ARTD8), catalytic fragment in complex with compound 2monomer1616-1801
100FDR;EDO;
Human PARP14 (ARTD8), catalytic fragment in complex with RBN011980monomer1616-1801
100YFG;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GV4;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;9KS;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GTJ;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GVV;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GUY;
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomer1208-1388
100CL;DMS;GQY;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GUG;
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomer1208-1388
100CL;DMS;AWP;
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomer1208-1388
100CL;DMS;GW1;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GUV;
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomer1208-1388
100CL;DMS;GVY;
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomer1208-1388
100CL;DMS;GV7;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GRY;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GRV;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GWA;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GT7;
HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3monomer1208-1388
100BR;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer1208-1388
100CL;DMS;GT4;
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomer1208-1388
100CL;DMS;GV1;
HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 IN COMPLEX WITH ADENOSINE- 5-DIPHOSPHORIBOSEmonomer1208-1388
100AR6;
The Crystal Structure of human PARP14 from Biortus.monomer1208-1387
100GOL;CL;

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5qhy.1.Amonomer0.901212-1387
GT4;100.00
3vfq.1.Amonomer0.86791-1191
AR6;100.00
5v7t.1.Amonomer0.731613-1801
100.00
8aly.1.Amonomer0.531553-1800
31.88

14 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 15qhy.1.Amonomer0.901131-1306
GT4;100.00
Isoform 13vfq.1.Amonomer0.86710-1110
AR6;100.00
Isoform 15v7t.1.Amonomer0.731532-1720
100.00
Isoform 18aly.1.Amonomer0.541472-1719
31.88
Isoform 35qhy.1.Amonomer0.90929-1104
GT4;100.00
Isoform 33vfq.1.Amonomer0.86508-908
AR6;100.00
Isoform 35v7t.1.Amonomer0.751330-1518
100.00
Isoform 38aly.1.Amonomer0.531270-1517
31.88
Isoform 45qhy.1.Amonomer0.901212-1387
GT4;100.00
Isoform 43vfq.1.Amonomer0.86791-1191
AR6;100.00
Isoform 55qhy.1.Amonomer0.91208-383
GT4;100.00
Isoform 53q71.1.Amonomer0.856-187
AR6;97.81
Isoform 57f41.1.Bmonomer0.79601-796
3AB;65.48
Isoform 58aly.1.Amonomer0.53549-796
32.31